MY110104A - Saccharin derivative proteolytic enzyme inhibitors - Google Patents
Saccharin derivative proteolytic enzyme inhibitorsInfo
- Publication number
- MY110104A MY110104A MYPI92002285A MYPI19922285A MY110104A MY 110104 A MY110104 A MY 110104A MY PI92002285 A MYPI92002285 A MY PI92002285A MY PI19922285 A MYPI19922285 A MY PI19922285A MY 110104 A MY110104 A MY 110104A
- Authority
- MY
- Malaysia
- Prior art keywords
- proteolytic enzyme
- enzyme inhibitors
- saccharin derivative
- derivative proteolytic
- saccharin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
- C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Bakery Products And Manufacturing Methods Therefor (AREA)
- Fertilizers (AREA)
- Beans For Foods Or Fodder (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81026591A | 1991-12-19 | 1991-12-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY110104A true MY110104A (en) | 1998-01-27 |
Family
ID=25203432
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI92002285A MY110104A (en) | 1991-12-19 | 1992-12-11 | Saccharin derivative proteolytic enzyme inhibitors |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0547708B1 (2) |
| JP (1) | JP3179600B2 (2) |
| KR (2) | KR100292995B1 (2) |
| AT (1) | ATE233250T1 (2) |
| AU (1) | AU668694B2 (2) |
| CA (1) | CA2084857A1 (2) |
| CZ (1) | CZ283257B6 (2) |
| DE (1) | DE69232929D1 (2) |
| FI (1) | FI925787A7 (2) |
| HU (1) | HU219950B (2) |
| IL (1) | IL104154A (2) |
| MX (1) | MX9207449A (2) |
| MY (1) | MY110104A (2) |
| NO (1) | NO300770B1 (2) |
| NZ (1) | NZ245518A (2) |
| RU (1) | RU2107685C1 (2) |
| SG (1) | SG52659A1 (2) |
| SK (1) | SK278390B6 (2) |
| TW (1) | TW225532B (2) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5378720A (en) * | 1991-12-19 | 1995-01-03 | Sterling Winthrop Inc. | Saccharin derivative proteolytic enzyme inhibitors |
| US5541168A (en) * | 1994-12-02 | 1996-07-30 | Sterling Winthrop Inc. | Substituted 2-(phosphinyloxymethyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof |
| US5512576A (en) * | 1994-12-02 | 1996-04-30 | Sterling Winthrop Inc. | 2-substituted 1,2,5,-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof |
| DE19533643A1 (de) * | 1995-09-12 | 1997-03-13 | Nycomed Arzneimittel Gmbh | Neue cyclische Derivate von Benzolsulfonamiden |
| US5750550A (en) * | 1995-09-15 | 1998-05-12 | Sanofi | 2-(pyrazol-5-yl-oxymethyl)-1,2-benzisothiazol-3 (2H)-One 1, 1-dioxides and compositions and method of use thereof |
| EP1465869B1 (en) | 2001-12-21 | 2013-05-15 | Exelixis Patent Company LLC | Modulators of lxr |
| US7482366B2 (en) | 2001-12-21 | 2009-01-27 | X-Ceptor Therapeutics, Inc. | Modulators of LXR |
| CN100486576C (zh) | 2002-02-14 | 2009-05-13 | 法玛西雅公司 | 作为p38map激酶调节剂的取代吡啶酮类 |
| TWI417095B (zh) | 2006-03-15 | 2013-12-01 | Janssen Pharmaceuticals Inc | １，４-二取代之３-氰基-吡啶酮衍生物及其作為ｍＧｌｕＲ２-受體之正向異位性調節劑之用途 |
| US8309545B2 (en) * | 2006-10-04 | 2012-11-13 | Bionomics Limited | Benzofuran potassium channel blockers and uses thereof |
| EP2097416B1 (en) | 2006-12-18 | 2012-09-12 | Amgen, Inc | Azaquinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof |
| WO2008076427A2 (en) | 2006-12-18 | 2008-06-26 | Amgen Inc. | Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof |
| TW200845978A (en) | 2007-03-07 | 2008-12-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
| TW200900065A (en) | 2007-03-07 | 2009-01-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives |
| ES2446418T3 (es) | 2007-04-18 | 2014-03-07 | Amgen, Inc | Derivados de indanona que inhiben la prolil hidroxilasa |
| CA2683956C (en) | 2007-04-18 | 2012-12-18 | Amgen Inc. | Quinolones and azaquinolones that inhibit prolyl hydroxylase |
| CA2685216C (en) | 2007-05-04 | 2014-07-08 | Amgen Inc. | Thienopyridine and thiazolopyridine derivatives that inhibit prolyl hydroxylase activity |
| EP2155746A2 (en) | 2007-05-04 | 2010-02-24 | Amgen, Inc | Diazaquinolones that inhibit prolyl hydroxylase activity |
| PL2203439T3 (pl) | 2007-09-14 | 2011-06-30 | Addex Pharmaceuticals Sa | 1',3'-dipodstawione-4-fenylo-3,4,5,6-tetrahydro-2H, 1'H-[1, 4']bipirydynylo-2'-ketony |
| ES2439291T3 (es) | 2008-09-02 | 2014-01-22 | Janssen Pharmaceuticals, Inc. | Derivados de 3-azabiciclo[3.1.0]hexilo como moduladores de receptores de glutamato metabotrópicos |
| ES2401691T3 (es) | 2008-11-28 | 2013-04-23 | Ortho-Mcneil-Janssen Pharmaceuticals, Inc. | Derivados de indol y de benzoxacina como moduladores de los receptores metabotrópicos de glutamato |
| MY153913A (en) | 2009-05-12 | 2015-04-15 | Janssen Pharmaceuticals Inc | 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| JP5634506B2 (ja) | 2009-05-12 | 2014-12-03 | ジャンセン ファーマシューティカルズ， インコーポレイテッド | １，２，３−トリアゾロ［４，３−ａ］ピリジン誘導体ならびに神経障害および精神障害の治療または予防のためのその使用 |
| AU2010246607B2 (en) | 2009-05-12 | 2012-09-27 | Addex Pharma S.A. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
| ES2552455T3 (es) | 2010-11-08 | 2015-11-30 | Janssen Pharmaceuticals, Inc. | Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2 |
| JP5852665B2 (ja) | 2010-11-08 | 2016-02-03 | ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド | １，２，４−トリアゾロ［４，３−ａ］ピリジン誘導体およびｍＧｌｕＲ２受容体のポジティブアロステリックモジュレーターとしてのそれらの使用 |
| JP5852666B2 (ja) | 2010-11-08 | 2016-02-03 | ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド | １，２，４−トリアゾロ［４，３−ａ］ピリジン誘導体およびｍＧｌｕＲ２受容体のポジティブアロステリックモジュレーターとしてのそれらの使用 |
| JO3368B1 (ar) | 2013-06-04 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2 |
| JO3367B1 (ar) | 2013-09-06 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2 |
| KR20220038826A (ko) | 2014-01-21 | 2022-03-29 | 얀센 파마슈티카 엔.브이. | 대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도 |
| KR20200036063A (ko) | 2014-01-21 | 2020-04-06 | 얀센 파마슈티카 엔.브이. | 대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4195023A (en) * | 1975-08-20 | 1980-03-25 | Merck & Co., Inc. | 2-(2-Furoyl)1,2-benzisothiazole-3-one, 2-(2-furoyl) saccharin, and 2-(2-thenoyl) saccharin |
| US4276298A (en) * | 1978-03-24 | 1981-06-30 | Merck & Co., Inc. | 2-Aryl-1,2-benzisothiazolinone-1,1-dioxides and their use as selective protease inhibitors |
| DE3617976A1 (de) * | 1986-05-28 | 1988-01-14 | Alter Sa | 1,4-dihydropyridin, verfahren zu dessen herstellung und dessen verwendung in antithrombotischen medikamenten |
| ATE159720T1 (de) * | 1989-05-04 | 1997-11-15 | Sanofi Sa | Saccharinderivate zur verwendung als proteolytische enzyminhibitoren sowie verfahren zur herstellung |
| AU642537B2 (en) * | 1990-11-01 | 1993-10-21 | Sanofi | 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| AU656027B2 (en) * | 1991-11-15 | 1995-01-19 | Sanofi | Saccharin derivative proteolytic enzime inhibitors |
-
1992
- 1992-11-12 AU AU28292/92A patent/AU668694B2/en not_active Ceased
- 1992-11-18 TW TW081109245A patent/TW225532B/zh active
- 1992-12-08 CA CA002084857A patent/CA2084857A1/en not_active Abandoned
- 1992-12-11 MY MYPI92002285A patent/MY110104A/en unknown
- 1992-12-15 DE DE69232929T patent/DE69232929D1/de not_active Expired - Lifetime
- 1992-12-15 EP EP92203917A patent/EP0547708B1/en not_active Expired - Lifetime
- 1992-12-15 SG SG1996007465A patent/SG52659A1/en unknown
- 1992-12-15 AT AT92203917T patent/ATE233250T1/de not_active IP Right Cessation
- 1992-12-17 KR KR1019920024707A patent/KR100292995B1/ko not_active Expired - Fee Related
- 1992-12-17 JP JP33703492A patent/JP3179600B2/ja not_active Expired - Fee Related
- 1992-12-18 NZ NZ245518A patent/NZ245518A/en unknown
- 1992-12-18 RU RU92016244A patent/RU2107685C1/ru not_active IP Right Cessation
- 1992-12-18 FI FI925787A patent/FI925787A7/fi unknown
- 1992-12-18 IL IL10415492A patent/IL104154A/en not_active IP Right Cessation
- 1992-12-18 MX MX9207449A patent/MX9207449A/es not_active IP Right Cessation
- 1992-12-18 HU HU9204029A patent/HU219950B/hu not_active IP Right Cessation
- 1992-12-18 NO NO924915A patent/NO300770B1/no unknown
- 1992-12-18 SK SK3746-92A patent/SK278390B6/sk unknown
- 1992-12-18 CZ CS923746A patent/CZ283257B6/cs not_active IP Right Cessation
-
2000
- 2000-10-20 KR KR1020000061842A patent/KR100378968B1/ko not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| NO300770B1 (no) | 1997-07-21 |
| SG52659A1 (en) | 1998-09-28 |
| SK374692A3 (en) | 1997-02-05 |
| DE69232929D1 (de) | 2003-04-03 |
| KR100292995B1 (ko) | 2001-09-17 |
| KR100378968B1 (ko) | 2003-04-08 |
| MX9207449A (es) | 1994-03-31 |
| SK278390B6 (en) | 1997-02-05 |
| AU2829292A (en) | 1993-07-08 |
| RU2107685C1 (ru) | 1998-03-27 |
| CZ374692A3 (en) | 1993-08-11 |
| CZ283257B6 (cs) | 1998-02-18 |
| HU219950B (hu) | 2001-09-28 |
| HU9204029D0 (en) | 1993-04-28 |
| NO924915L (no) | 1993-06-21 |
| NZ245518A (en) | 1995-06-27 |
| IL104154A0 (en) | 1993-05-13 |
| IL104154A (en) | 1996-09-12 |
| EP0547708A1 (en) | 1993-06-23 |
| FI925787L (fi) | 1993-06-20 |
| FI925787A0 (fi) | 1992-12-18 |
| AU668694B2 (en) | 1996-05-16 |
| ATE233250T1 (de) | 2003-03-15 |
| JP3179600B2 (ja) | 2001-06-25 |
| NO924915D0 (no) | 1992-12-18 |
| CA2084857A1 (en) | 1993-06-20 |
| FI925787A7 (fi) | 1993-06-20 |
| HUT67039A (en) | 1995-01-30 |
| JPH05345771A (ja) | 1993-12-27 |
| EP0547708B1 (en) | 2003-02-26 |
| TW225532B (2) | 1994-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY110104A (en) | Saccharin derivative proteolytic enzyme inhibitors | |
| MY129998A (en) | Saccharin derivative proteolytic enzyme inhibitors | |
| BG104780A (en) | Inhibitors of phospholipase enzymes | |
| BG102945A (en) | Carbamide derivatives as inhibitors of enzyme inosine-5'-monophosphate dehydrogenase | |
| MY106202A (en) | Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof. | |
| PL331802A1 (en) | Substituted cyclic amines as metaloprotease inhibitors | |
| MX9206008A (es) | Inhibidores de enzima proteolitica, derivados de sacarina 2-substituida. | |
| CA2293706A1 (en) | N-substituted urea inhibitors of farnesyl-protein transferase | |
| HU9403343D0 (en) | New pharmaceutical uses of krill enzymes | |
| BG109411A (en) | METHOD FOR OBTAINING HIV-PROTEZATE INHIBITORS | |
| DE69926078D1 (en) | Farnesyl-protein transferase inhibitoren | |
| AU7470098A (en) | Antithrombotic agents | |
| GEP20012440B (en) | Biphenylsulfonamide Matrix Metalloproteinase Inhibitors | |
| GEP20033130B (en) | Inhibitors of IMPDH Enzyme | |
| GEP20022764B (en) | HIV Protease Inhibitors, Pharmaceutical Compositions and Methods for Inhibiting HIV Protease |